Register


Create a profile to access all of our events, including options to sign up for our in person meetings and to view the online content from our past conferences!


Video Platform

View all the content from the last 12 months

MD Newsletter

Stay up to date with everything MD Education

Tickets & Events

Save your space and register for our future events

Select what applies to you




Login

Gaining access to MD Education’s premium offerings is only a button away! Enter your email and password to get educated.

MD-Education logo
Register / Login
We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!


Questions? Contact us at:


office@md-education.com

Want Cookies?


Currently, we're using cookies for tracking purposes. By tracking, we mean what pages of MD Education you visit, what forms you submit and how you interact with our site. We do not sell this data to anybody. Currently, the Cookies we use are needed to collect form data through HubSpot.


If you'd like to see what we do with your data, head over to our Privacy Policy


4th Annual

Thank you for registering to our ASH Satillite Symposium!

Please check your emails for registration confirmation.


AML-ALL

EU Focus Meeting

Updating Knowledge & Clinical Practice in 2025


President Hotel, Athens, Greece

October 24 - 25, 2025

For more information get in touch!

=

Co-chair

Charlie Craddock, MD

Queen Elizabeth Hospital, Birmingham, UK

=

Co-chair

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX

=

Co-chair

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX

=

Co-chair

Cristina Papayannidis, MD

University of Bologna, Italy

Dear Colleagues and Friends,


We are delighted to extend our warmest invitation to the multinational congress AML-ALL EU Focus 2025, to be held at President Hotel, Athens, Greece on the 24th of October, 2025 to the 25th of October, 2025.


This congress provides pivotal collaboration aimed at advancing AML-ALL research and patient treatment.


This congress presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts from around the world.


Engage in riveting presentations, participate in thought-provoking debates, round-table discussions, and connect with peers at informal social gatherings.



People stood in a circle, smiling, with a cup of water

Agenda & Faculty

AML-ALL EU Focus Meeting, Friday 24 October 2025 - Saturday 25 October 2025

7:00 AM

Registration Opens

Session 1: TBD

8:00 AM

Evolving Treatment Paradigms in Fit Adults with Newly Diagnosed AML

=

Hagop Kantarjian, MD

MD Anderson Cancer Center, Houston, TX

8:20 AM

Integrating Genomics and MRD in Treatment Decision Making in Fit Adult AML

=

Paresh Vyas, MD

University of Oxford, UK

8:40 AM

Integrating Genomics and MRD in Treatment Decision Making in Fit Adult AML

=

Christoph Röllig, MD

University Hospital Carl Gustav Carus, Dresden, Germany

9:00 AM

Treatment options in TP53 mutated AML

=

David Sallman, MD

Moffitt Cancer Center, Tampa, FL

9:20 AM

Transplant in AML CR1: who, when and how?

=

Victoria Potter, MD

King’s College Hospital NHS Foundation Trust, London, UK

9:40 AM

Panel Discussion

10:00 AM

Coffee Break & Networking

Session 2: TBD

10:20 AM

Risk stratification of ALL

=

Anthony Moorman, MD

Newcastle University, UK

10:40 AM

New molecular insights in ALL

=

Ilaria Iacobucci, MD

St. Jude Children’s Research Hospital, Memphis, TN

11:00 AM

How I Treat Ph Positive ALL

=

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX

11:20 AM

MRD in Ph+ ALL: BCR-ABL and/or NGS?

=

Monika Brüggemann, MD

University Medical Center Schleswig-Holstein, Germany

11:40 AM

SCT in Ph+ ALL: for which patients?

=

Jose Maria Ribera, MD

Catalan Institute of Oncology, Spain

12:00 PM

Panel Discussion

12:20 PM

Lunch Break, Networking + Faculty and Fellow Photo

Session 3: TBD

1:20 PM

Management of APML in 2025

=

Steve Knapper, MD

Cardiff University, UK

1:40 PM

Which Patients with Newly Diagnosed AML Should Receive a Venetoclax Based Regimen in 2024

=

Michael Dennis, MD

The Christie NHS Foundation Trust, UK

2:00 PM

Improving Outcomes in Patients Treated with HMA+Venetoclax Based Regimens

=

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX

2:20 PM

Integrating Menin Inhibitors into the Management of Fit and Unfit Adults with AML

=

Emma Searle, MD

The Christie NHS Foundation Trust, Manchester, UK

2:40 PM

Panel Discussion

3:00 PM

Coffee Break & Networking

Session 4: TBD

3:20 PM

Translational research ABL-class ALL and clinical implications in diagnosis, choice of TKI and disease monitoring

=

Monique L. den Boer, MD

The Princess Máxima Center, Utrecht, Netherlands

3:40 PM

How can we eradicate MRD in Ph neg ALL

=

Nicola Gökbuget, MD

Universitätsmedizin Frankfurt, Germany

4:00 PM

Panel Discussion

4:20 PM

First line therapy in Ph neg ALL: AYA

=

Nicolas Boissel, MD

Assistance Publique – Hôpitaux de Paris, France

4:40 PM

First line therapy in Ph neg ALL: AYA

=

Anna Castleton, MD

The Christie NHS Foundation Trust, Manchester, UK

5:20 PM

How I treat Ph like ALL

=

Sabina Chiaretti, MD

Universita di Bologna Italy

5:40 PM

Panel Discussion

6:00 PM

Adjourn